summary: This study of stem-cell therapy in an animal model of MS showed improvement of the clinical signs, inflammation and brain injury. However these changes were not due to remyelination, instead appearing to be related to a change in the immune response.

authors: Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T

source: PLoS ONE. 2008 Sep 5;3(9):e3145

weblink: click here

category: Cell Biology

related research news: click here

glossary: